Extended follow-up of efficacy and safety of larotrectinib in patients with TRK fusion lung cancer Meeting Abstract


Authors: Moreno, V.; Lin, J. J.; Tan, D. S. W.; Kummar, S.; Dai, M. S.; Lassen, U. N.; Leyvraz, S.; Liu, Y.; Patel, J. D.; Rosen, L.; Solomon, B.; Yachnin, J.; Norenberg, R.; Fellous, M.; Mussi, C. E.; Shen, L.; Drilon, A.
Abstract Title: Extended follow-up of efficacy and safety of larotrectinib in patients with TRK fusion lung cancer
Meeting Title: 2022 World Conference on Lung Cancer
Journal Title: Journal of Thoracic Oncology
Volume: 17
Issue: 9 Suppl.
Meeting Dates: 2022 Aug 6-9
Meeting Location: Vienna, Austria
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2022-09-01
Start Page: S473
End Page: S474
Language: English
DOI: 10.1016/j.jtho.2022.07.831
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: EP08.02-148 -- Located within section named "EP08.02 Metastatic Non-Small Cell Lung Cancer - Molecular Targeted Treatments" -- Accession Number: 159038077 -- Entry Date: In Process -- Revision Date: 20220913 -- Publication Type: Article -- Supplement Title: 2022 Supplement -- Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101274235. -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon